These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16173792)

  • 1. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
    Grigalevicius S; Chierici S; Renaudet O; Lo-Man R; Dériaud E; Leclerc C; Dumy P
    Bioconjug Chem; 2005; 16(5):1149-59. PubMed ID: 16173792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.
    Lo-Man R; Bay S; Vichier-Guerre S; Dériaud E; Cantacuzène D; Leclerc C
    Cancer Res; 1999 Apr; 59(7):1520-4. PubMed ID: 10197623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advance in carbohydrate-based cancer vaccines].
    Huo CX; Ye XS
    Yao Xue Xue Bao; 2012 Mar; 47(3):261-70. PubMed ID: 22645748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation.
    Geraci C; Consoli GM; Galante E; Bousquet E; Pappalardo M; Spadaro A
    Bioconjug Chem; 2008 Mar; 19(3):751-8. PubMed ID: 18293897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
    Vichier-Guerre S; Lo-Man R; Huteau V; Dériaud E; Leclerc C; Bay S
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3567-70. PubMed ID: 15177475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses and Immunological Evaluation of Self-Adjuvanting Clustered N-Acetyl and N-Propionyl Sialyl-Tn Combined with a T-helper Cell Epitope as Antitumor Vaccine Candidates.
    Chang TC; Manabe Y; Fujimoto Y; Ohshima S; Kametani Y; Kabayama K; Nimura Y; Lin CC; Fukase K
    Angew Chem Int Ed Engl; 2018 Jul; 57(27):8219-8224. PubMed ID: 29768704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and immunological evaluation of N-acyl modified Tn analogues as anticancer vaccine candidates.
    Song C; Sun S; Huo CX; Li Q; Zheng XJ; Tai G; Zhou Y; Ye XS
    Bioorg Med Chem; 2016 Feb; 24(4):915-20. PubMed ID: 26787275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.
    Freire T; Lo-Man R; Piller F; Piller V; Leclerc C; Bay S
    Glycobiology; 2006 May; 16(5):390-401. PubMed ID: 16449349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.
    Buskas T; Ingale S; Boons GJ
    Angew Chem Int Ed Engl; 2005 Sep; 44(37):5985-8. PubMed ID: 16108081
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
    De Silva RA; Wang Q; Chidley T; Appulage DK; Andreana PR
    J Am Chem Soc; 2009 Jul; 131(28):9622-3. PubMed ID: 19552408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of selected LeY and KH-1 analogues: a medicinal chemistry approach to vaccine optimization.
    Spassova MK; Bornmann WG; Ragupathi G; Sukenick G; Livingston PO; Danishefsky SJ
    J Org Chem; 2005 Apr; 70(9):3383-95. PubMed ID: 15844973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
    Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
    Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidates.
    Huo CX; Zheng XJ; Xiao A; Liu CC; Sun S; Lv Z; Ye XS
    Org Biomol Chem; 2015 Mar; 13(12):3677-90. PubMed ID: 25679360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity.
    Laubreton D; Bay S; Sedlik C; Artaud C; Ganneau C; Dériaud E; Viel S; Puaux AL; Amigorena S; Gérard C; Lo-Man R; Leclerc C
    Cancer Immunol Immunother; 2016 Mar; 65(3):315-25. PubMed ID: 26847142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
    Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.
    Pifferi C; Thomas B; Goyard D; Berthet N; Renaudet O
    Chemistry; 2017 Nov; 23(64):16283-16296. PubMed ID: 28845889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.
    Lo-Man R; Vichier-Guerre S; Perraut R; Dériaud E; Huteau V; BenMohamed L; Diop OM; Livingston PO; Bay S; Leclerc C
    Cancer Res; 2004 Jul; 64(14):4987-94. PubMed ID: 15256473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a single-molecule L-rhamnose-containing three-component vaccine and evaluation of antigenicity in the presence of anti-L-rhamnose antibodies.
    Sarkar S; Lombardo SA; Herner DN; Talan RS; Wall KA; Sucheck SJ
    J Am Chem Soc; 2010 Dec; 132(48):17236-46. PubMed ID: 21080675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand.
    Abdel-Aal AB; El-Naggar D; Zaman M; Batzloff M; Toth I
    J Med Chem; 2012 Aug; 55(15):6968-74. PubMed ID: 22800462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine.
    Monzavi-Karbassi B; Pashov A; Jousheghany F; Artaud C; Kieber-Emmons T
    Int J Mol Med; 2006 Jun; 17(6):1045-52. PubMed ID: 16685414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.